| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 4,680 | $40 | $173.2K |
| J9271 | Injection, pembrolizumab, 1 mg | 3,800 | $40 | $163.5K |
| J9299 | Injection, nivolumab, 1 mg | 5,240 | $20 | $120.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 140 | $100 | $13.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 90 | $130 | $12.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 70 | $140 | $8.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 40 | $70 | $3.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 40 | $70 | $2.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 20 | $170 | $2.7K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 170 | $10 | $2.1K |